Neuromodulation: Devices's Stimulating Growth Market

According to "Opportunities in Global Medical Devices and Diagnostics," a report recently published by Health Research International that forecasts growth rates in seven major clinical segments and 20 major technology segments, neuromodulation will experience the highest growth rate of all the top-tier segments over the next five years, in excess of 18%. The neuromodulation segment posted sales of approximately $1.7 billion in 2005 and will be worth almost $4 billion in 2010, HRI predicts.

Devices are increasingly infiltrating clinical segments where once only drugs held sway, and nowhere more so than in neuromodulation. These implantable devices can therapeutically influence the activity of the body's nervous system, either electrically or pharmacologically, and they're reaching into conventional drug markets such as pain, depression, chronic migraines, and epilepsy.

According to "Opportunities in Global Medical Devices and Diagnostics," a report recently published by Health Research International (HRI) and distributed...

More from Archive

More from Medtech Insight